EQUITY (Tables)
|
12 Months Ended |
Dec. 31, 2022 |
|---|
| Equity [Abstract] |
|
| Reconciliation Of Common Stock Issued |
The following table reconciles common stock reported in the consolidated statements of changes in equity to the consolidated balance sheets.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
2022 |
|
2021 |
| Common shares issued as reported in the consolidated statement of changes in equity |
|
228,498,102 |
|
|
221,964,734 |
|
| Unissued retirement eligible restricted stock awards |
|
18,250 |
|
|
65,625 |
|
| Unvested restricted stock awards |
|
995,691 |
|
|
860,244 |
|
| Unvested deferred stock awards issued |
|
2,159,604 |
|
|
2,192,000 |
|
| Common shares issued as reported in the consolidated balance sheets |
|
231,671,647 |
|
|
225,082,603 |
|
|
| Change in Noncontrolling Ownership Interest |
The following schedule reflects the change in ownership interests for these transactions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Year Ended December 31, |
| |
2022 |
|
2021 |
|
2020 |
| |
(in thousands) |
Net income (loss) attributable to common stockholders of Live Nation |
$ |
295,986 |
|
|
$ |
(650,904) |
|
|
$ |
(1,724,535) |
|
| Transfers of noncontrolling interests: |
|
|
|
|
|
Changes in Live Nation’s additional paid-in capital for purchases of noncontrolling interests, net of transaction costs |
(64,601) |
|
|
(110) |
|
|
14,336 |
|
Changes in Live Nation’s additional paid-in capital for sales of noncontrolling interests, net of transaction costs |
— |
|
|
(289) |
|
|
(7,667) |
|
| Net transfers of noncontrolling interests |
(64,601) |
|
|
(399) |
|
|
6,669 |
|
Change from net income (loss) attributable to common stockholders of Live Nation and net transfers of noncontrolling interests |
$ |
231,385 |
|
|
$ |
(651,303) |
|
|
$ |
(1,717,866) |
|
|
| Schedule of Accumulated Other Comprehensive Income (Loss) |
The following table presents changes in the components of AOCI, net of taxes, for the years ended December 31, 2022, 2021 and 2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on Cash Flow Hedges |
|
|
|
Foreign Currency Items |
|
|
|
Total |
|
|
(in thousands) |
| Balance at December 31, 2019 |
|
$ |
— |
|
|
|
|
$ |
(145,713) |
|
|
|
|
$ |
(145,713) |
|
| Other comprehensive income (loss) before reclassifications |
|
(36,689) |
|
|
|
|
291 |
|
|
|
|
(36,398) |
|
| Amount reclassified from AOCI |
|
5,102 |
|
|
|
|
— |
|
|
|
|
5,102 |
|
| Net other comprehensive income (loss) |
|
(31,587) |
|
|
|
|
291 |
|
|
|
|
(31,296) |
|
| Balance at December 31, 2020 |
|
(31,587) |
|
|
|
|
(145,422) |
|
|
|
|
(177,009) |
|
| Other comprehensive income before reclassifications |
|
15,204 |
|
|
|
|
6,016 |
|
|
|
|
21,220 |
|
| Amount reclassified from AOCI |
|
7,825 |
|
|
|
|
— |
|
|
|
|
7,825 |
|
| Net other comprehensive income |
|
23,029 |
|
|
|
|
6,016 |
|
|
|
|
29,045 |
|
| Balance at December 31, 2021 |
|
(8,558) |
|
|
|
|
(139,406) |
|
|
|
|
(147,964) |
|
| Other comprehensive income before reclassifications |
|
49,529 |
|
|
|
|
8,047 |
|
|
|
|
57,576 |
|
| Amount reclassified from AOCI |
|
312 |
|
|
|
|
— |
|
|
|
|
312 |
|
| Net other comprehensive income |
|
49,841 |
|
|
|
|
8,047 |
|
|
|
|
57,888 |
|
| Balance at December 31, 2022 |
|
$ |
41,283 |
|
|
|
|
$ |
(131,359) |
|
|
|
|
$ |
(90,076) |
|
|
| Computation of Weighted Average Common Shares Outstanding |
The following table sets forth the computation of weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
2022 |
|
2021 |
|
2020 |
| Weighted average common shares—basic |
|
224,809,558 |
|
|
217,190,862 |
|
|
212,270,944 |
|
| Effect of dilutive shares: |
|
|
|
|
|
|
| Stock options and restricted stock |
|
6,747,308 |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
| Weighted average common shares—diluted |
|
231,556,866 |
|
|
217,190,862 |
|
|
212,270,944 |
|
|
| Potentially Dilutive Securities Excluded From Diluted Net Income Per Common Share |
The following table shows securities excluded from the calculation of diluted net income per common share because such securities were anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
|
2022 |
|
2021 |
|
2020 |
| Options to purchase shares of common stock |
|
3,750 |
|
|
7,719,714 |
|
|
9,323,323 |
|
| Restricted and deferred stock awards—unvested |
|
2,218,563 |
|
|
3,052,244 |
|
|
3,956,073 |
|
|
|
|
|
|
|
|
Conversion shares related to convertible senior notes |
|
11,864,035 |
|
|
11,864,035 |
|
|
11,014,846 |
|
Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding |
|
14,086,348 |
|
|
22,635,993 |
|
|
24,294,242 |
|
|